Pei-Ming Chu Selected Research

Pei-Ming Chu Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 01/2011
12	Inflammation (Inflammations) 09/2023 - 07/2016
6	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 10/2015
5	Atherosclerosis 01/2021 - 07/2016
4	Hepatocellular Carcinoma (Hepatoma) 03/2023 - 03/2011
4	Fibrosis (Cirrhosis) 09/2022 - 02/2018
3	Mouth Neoplasms (Oral Cancer) 05/2022 - 11/2017
3	Neoplasm Metastasis (Metastasis) 12/2021 - 11/2017
3	Glioma (Gliomas) 01/2013 - 01/2011
2	Carcinoma (Carcinomatosis) 05/2022 - 01/2022
2	Obesity 01/2019 - 10/2016
2	Wounds and Injuries (Trauma) 10/2016 - 03/2016
2	Glioblastoma (Glioblastoma Multiforme) 01/2013 - 01/2011
1	Heart Failure 09/2022
1	Cardiomyopathies (Cardiomyopathy) 09/2022
1	Hypertrophy 09/2022
1	Cardiotoxicity 09/2022
1	Ischemic Stroke 03/2022
1	Atrophy 12/2021
1	Myotoxicity 12/2021
1	Fatigue 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Periodontal Diseases (Periodontal Disease) 12/2020
1	Gingival Overgrowth 08/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Ischemia 01/2020
1	Thrombosis (Thrombus) 07/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2019
1	Oral Submucous Fibrosis 08/2018
1	Hyperhomocysteinemia 01/2018
1	Squamous Cell Carcinoma of Head and Neck 11/2017
1	Carcinogenesis 11/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2017

Drug/Important Bio-Agent (IBA)

7	AntioxidantsIBA 09/2022 - 07/2016
6	oxidized low density lipoproteinIBA 01/2019 - 10/2015
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 03/2011
5	Sirtuin 1IBA 12/2021 - 10/2016
4	Long Noncoding RNAIBA 05/2021 - 08/2018
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 03/2011
3	BO-1051IBA 03/2012 - 01/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2023 - 10/2015
2	Fibronectins (Fibronectin)IBA 09/2022 - 04/2020
2	AnthracyclinesIBA 09/2022 - 12/2021
2	CytokinesIBA 03/2022 - 12/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 01/2018
2	baicaleinIBA 11/2016 - 07/2016
1	Angiotensin IIIBA 09/2023
1	Sorafenib (BAY 43-9006)FDA Link 03/2023
1	Protein Tyrosine PhosphatasesIBA 01/2023
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2023
1	CollagenIBA 09/2022
1	Sodium-Glucose Transport ProteinsIBA 09/2022
1	Atrial Natriuretic Factor (ANF)IBA 09/2022
1	dapagliflozinIBA 09/2022
1	Aldehyde Dehydrogenase 1 FamilyIBA 05/2022
1	butylidenephthalideIBA 05/2022
1	magnololIBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 12/2021
1	Etoposide (VP 16)FDA LinkGeneric 12/2021
1	TeaIBA 01/2021
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021
1	cordycepinIBA 01/2021
1	HomocysteineIBA 01/2021
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2021
1	PhytochemicalsIBA 12/2020
1	Oxidants (Oxidizing Agents)IBA 12/2020
1	Small Interfering RNA (siRNA)IBA 08/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2020
1	Interleukin-8 (Interleukin 8)IBA 04/2020
1	Collagen Type I (Type I Collagen)IBA 04/2020
1	Heme (Haem)IBA 01/2020
1	Carbon MonoxideIBA 01/2020
1	Heme Oxygenase-1IBA 01/2020
1	interleukin 20 (IL-20)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 07/2019
1	Galectin 3 (LGALS3)IBA 07/2019
1	fucoxanthinIBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	tricarbonyldichlororuthenium (II) dimerIBA 01/2019
1	Particulate MatterIBA 01/2019
1	InflammasomesIBA 01/2019
1	Arecoline (Arecolin)IBA 02/2018
1	glabridinIBA 02/2018
1	Chlorogenic AcidIBA 01/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 11/2017
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	Chalcone (Benzalacetophenone)IBA 11/2017
1	FlavonoidsIBA 11/2017
1	isoliquiritigenin (GU 17)IBA 11/2017
1	Messenger RNA (mRNA)IBA 11/2017
1	chicoric acidIBA 05/2017
1	Apolipoproteins B (ApoB)IBA 11/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2016
1	LipidsIBA 11/2016

Therapy/Procedure

5	Therapeutics 05/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 09/2022 - 11/2017
1	Transplantation 03/2022
1	Lasers (Laser) 12/2021
1	Oral Hygiene (Dental Hygiene) 08/2020